This episode of Pharma Pulse explores AbbVie’s $195 million investment to expand US API production, new survey results ...

Basilea has acquired the global rights for Venatorx Pharmaceuticals’ ceftibuten-ledaborbactam etzadroxil, an antibiotic being ...

From Barnes & Noble's new Germantown location to Frutta Bowls' plans to enter the market, here's a look at the suburban development scene.

No additional tariffs have been imposed on Indian exports to the United States in key sectors such as pharmaceuticals and ...

The Swiss government met with executives of Roche Holding AG and Novartis AG to discuss the pharmaceutical industry’s situation in light of US tariffs.

Iqvia easily belongs in the top tier of large, global CROs with the infrastructure to win these contracts, and its size means it works on more clinical trials than any competitor, further sharpening ...

Key Points Revenue (GAAP) increased 91.3% year-over-year to $15.3 million, compared to $8.0 million in Q2 2024, beating the consensus estimate by $1.2 million (GAAP). Net loss per share (GAAP) ...

But rising Chinese import tariffs due to the trade war with the U.S. and longer-term concerns about costs or access are ...

The announcement by President Donald Trump's administration of the results of a probe into pharmaceutical imports and new ...

The Q2 pharma earnings season featured changes in the obesity race as well as insights into drugmakers’ views on tariffs and drug pricing.

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

By 2012, saddled with billions in debt, Kodak filed for Chapter 11 bankruptcy. However, Zhang traced the decay back even ...